2. 您的位置
3. 首页
4. 会议论文
5. Novel polysaccharide-based antimicrobial and biocompatible materials

Novel polysaccharide-based antimicrobial and biocompatible materials

来源 :2015年全国药物化学学术会议暨第五届中英药物化学学术会议 | 被引量 : 0次 | 上传用户：TSSSSSS

【摘 要】

：

Microbial infections endanger public health unremittingly and cause a huge economic burden to our society.Numerous efforts have been made to develop molecules which are able to inhibit pathogens.Novel

【作 者】

：

Peng Li 

【机 构】

：

Center for Biomedical Engineering and Regenerative Medicine,Frontier Institute of Science and Techno

【出 处】

：

2015年全国药物化学学术会议暨第五届中英药物化学学术会议

【发表日期】

：

2015年3期

【关键词】

：

antimicrobial polymers antimicrobial peptides surface coatings polysaccharides 

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　Microbial infections endanger public health unremittingly and cause a huge economic burden to our society.Numerous efforts have been made to develop molecules which are able to inhibit pathogens.Novel broad-spectrum antimicrobial materials were developed based on natural polysaccharide.

其他文献

桃金娘科植物间苯三酚类成分研究

会议

Discovery of ROR t Inverse Agonists for Autoimmune Diseases

Retinoid-related orphan receptor gamma-t(RORγt)is a key regulator for the development and functions of Th17 cells which are implicated in the pathology of a variety of human inflammatory and autoimmun

会议

RORγt inhibitorTh17 cell differentiationaryl amidesEAE

Aptamers Modified with D-/L-Isonucleoside and their Structure and Function Studies

The heterogeneous nuclear ribonucleoprotein A1(hnRNP A1)was reported to be participated in variety of tumors development.Previously,we isolated an hnRNP A1-specific DNA aptamer BC15,that can evaluate

会议

FGFR 抑制剂衍生物的设计、合成及抗胃癌活性评价

英国阿斯利康公司报道了一种新型成纤维细胞生长因子受体(FGFR)高选择性抑制剂——AZD4547[1].AZD4547 主要利用胃癌肿瘤细胞表面高表达的FGFR受体作为靶点,可作为ATP 与FGFR 结合的竞争性抑制剂,抑制肿瘤细胞增殖,使肿瘤细胞凋亡.目前,AZD4547 正处于胃癌治疗的临床Ⅱ期研究中.

会议

FGFR抑制剂AZD4547设计合成抗胃癌细胞活性

天然活性成分构效关系与作用机制研究

会议

Identification and Structure-Activity Relationships of Novel Dual-acting Agents to Improving Therape

The development of estrogen receptor(ER)ligands has emerged as active study field in fight against breast cancer,some of these have been termed selective estrogen receptor modulators(SERMs)because the

会议

Estrogen receptorHistone deacetylaseBreast cancerConjugates

Evolution of 1st,2nd and 3rd Generation EGFR Inhibitors Against NSCLC

会议

基于Aβ构象捕获的抗AD 类抗体活性肽研究

会议

Diverse Library Synthesis of Tanshinone I Analogues and their Potential to Overcome Tumor Multidrug

Multidrug resistance(MDR)is a major obstacle that leads to most tumor treatment failures.Thus,it is imperative to develop new approach and design new chemotherapy to overcome this challenge.Recently,t

会议

TanshinoneDiversity-oriented synthesisModificationMultidrug resistanceSTAT3

新型长效DPP-IV 抑制剂的发现

糖尿病是当前威胁全球人类健康的最重要的慢性非传染性疾病之一.根据国际糖尿病联盟(IDF)的最新统计,2014年全球糖尿病患者人数已达3.87亿,且到2035年估计将有5.92亿病例,而目前中国成人糖尿病患者数量预计已超过1亿,居全球首位.因此,治疗糖尿病的新型药物的研发是全球关注的热点之一.

会议

DPP-IV药物设计天然产物